Fundraising Fox

Convergentgenomics

Founded 2015 · 25 employees on LinkedIn · 1 known investors

Convergent Genomics is a genomic diagnostics company that uses next-generation sequencing and liquid biopsy to extract DNA from urine and detect, monitor, and predict urothelial (bladder) cancer non-invasively. Its test targets earlier cancer recurrence detection for clinicians and patients.

Founders & leadership

Convergentgenomics was founded in 2015 by Trevor Levin.

TL
Trevor LevinFounder, President & Chief Scientific Officer
BS
Brian SlingerlandChief Executive Officer
BMBrian Mazzarella
Brian MazzarellaChief Medical Officer
IH
Iden HaddadzadehChief Operating Officer

Investors · 1

Competitors · 2

by search overlap

Companies competing with Convergentgenomics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Convergentgenomics do?
Convergent Genomics is a genomic diagnostics company that uses next-generation sequencing and liquid biopsy to extract DNA from urine and detect, monitor, and predict urothelial (bladder) cancer non-invasively. Its test targets earlier cancer recurrence detection for clinicians and patients.
Who founded Convergentgenomics?
Convergentgenomics was founded by Trevor Levin in 2015.
Who are Convergentgenomics's investors?
Convergentgenomics's investors include Civilization Ventures Management, Llc.
Convergentgenomics — Investors & Founders | Fundraising Fox